246 related articles for article (PubMed ID: 23685932)
1. Long-term cognitive function, neuroimaging, and quality of life in primary CNS lymphoma.
Doolittle ND; Korfel A; Lubow MA; Schorb E; Schlegel U; Rogowski S; Fu R; Dósa E; Illerhaus G; Kraemer DF; Muldoon LL; Calabrese P; Hedrick N; Tyson RM; Jahnke K; Maron LM; Butler RW; Neuwelt EA
Neurology; 2013 Jul; 81(1):84-92. PubMed ID: 23685932
[TBL] [Abstract][Full Text] [Related]
2. A prospective phase II trial of response adapted whole brain radiotherapy after high dose methotrexate based chemotherapy in patients with newly diagnosed primary central nervous system lymphoma-analysis of acute toxicity profile and early clinical outcome.
Adhikari N; Biswas A; Gogia A; Sahoo RK; Garg A; Nehra A; Sharma MC; Bhasker S; Singh M; Sreenivas V; Chawla R; Joshi G; Kumar L; Chander S
J Neurooncol; 2018 Aug; 139(1):153-166. PubMed ID: 29633112
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal cognitive assessment in patients with primary CNS lymphoma treated with induction chemotherapy followed by reduced-dose whole-brain radiotherapy or autologous stem cell transplantation.
Correa DD; Braun E; Kryza-Lacombe M; Ho KW; Reiner AS; Panageas KS; Yahalom J; Sauter CS; Abrey LE; DeAngelis LM; Omuro A
J Neurooncol; 2019 Sep; 144(3):553-562. PubMed ID: 31377920
[TBL] [Abstract][Full Text] [Related]
4. Cognitive functions in primary CNS lymphoma after single or combined modality regimens.
Correa DD; Shi W; Abrey LE; Deangelis LM; Omuro AM; Deutsch MB; Thaler HT
Neuro Oncol; 2012 Jan; 14(1):101-8. PubMed ID: 22013168
[TBL] [Abstract][Full Text] [Related]
5. Cognitive functions in survivors of primary central nervous system lymphoma.
Correa DD; DeAngelis LM; Shi W; Thaler H; Glass A; Abrey LE
Neurology; 2004 Feb; 62(4):548-55. PubMed ID: 14981169
[TBL] [Abstract][Full Text] [Related]
6. Long-term remission of primary central nervous system lymphoma by intensified methotrexate chemotherapy.
Watanabe T; Katayama Y; Yoshino A; Komine C; Yokoyama T; Fukushima T
J Neurooncol; 2003 May; 63(1):87-95. PubMed ID: 12814260
[TBL] [Abstract][Full Text] [Related]
7. Balancing relapses versus cognitive impairment in primary central nervous system lymphoma: a single-center experience.
Chanswangphuwana C; Rojnuckarin P; Cherdchoo N; Raiyawa T; Uaprasert N
Hematology; 2018 Aug; 23(7):385-390. PubMed ID: 29256330
[TBL] [Abstract][Full Text] [Related]
8. Neuropsychological outcome after chemotherapy for primary CNS lymphoma: a prospective study.
Fliessbach K; Helmstaedter C; Urbach H; Althaus A; Pels H; Linnebank M; Juergens A; Glasmacher A; Schmidt-Wolf IG; Klockgether T; Schlegel U
Neurology; 2005 Apr; 64(7):1184-8. PubMed ID: 15824344
[TBL] [Abstract][Full Text] [Related]
9. Primary CNS lymphoma in patients younger than 60: can whole-brain radiotherapy be deferred?
Omuro A; Taillandier L; Chinot O; Sierra Del Rio M; Carnin C; Barrie M; Soussain C; Tanguy ML; Choquet S; Leblond V; Hoang-Xuan K;
J Neurooncol; 2011 Aug; 104(1):323-30. PubMed ID: 21170569
[TBL] [Abstract][Full Text] [Related]
10. Cognitive status and quality of life after treatment for primary CNS lymphoma.
Harder H; Holtel H; Bromberg JE; Poortmans P; Haaxma-Reiche H; Kluin-Nelemans HC; Menten J; van den Bent MJ
Neurology; 2004 Feb; 62(4):544-7. PubMed ID: 14981168
[TBL] [Abstract][Full Text] [Related]
11. Prospective cognitive follow-up in primary CNS lymphoma patients treated with chemotherapy and reduced-dose radiotherapy.
Correa DD; Rocco-Donovan M; DeAngelis LM; Dolgoff-Kaspar R; Iwamoto F; Yahalom J; Abrey LE
J Neurooncol; 2009 Feb; 91(3):315-21. PubMed ID: 18974934
[TBL] [Abstract][Full Text] [Related]
12. Maintenance of multi-domain neurocognitive functions in patients with newly-diagnosed primary CNS lymphoma after primary cranial radiotherapy combined with methotrexate-based chemotherapy: A preliminary case-series study.
Lin SY; Chuang CC; Tsan DL; Hung YS; Fu CJ; Shen YL; Chiang YY; Huang YC; Lu YJ; Yang CC
Appl Neuropsychol Adult; 2022; 29(3):432-441. PubMed ID: 32301346
[TBL] [Abstract][Full Text] [Related]
13. Results of whole-brain radiation as salvage of methotrexate failure for immunocompetent patients with primary CNS lymphoma.
Nguyen PL; Chakravarti A; Finkelstein DM; Hochberg FH; Batchelor TT; Loeffler JS
J Clin Oncol; 2005 Mar; 23(7):1507-13. PubMed ID: 15735126
[TBL] [Abstract][Full Text] [Related]
14. [Management of primary central nervous system lymphoma].
Gonzalez-Aguilar A; Houillier C; Soussain C; Hoang-Xuan K
Rev Neurol (Paris); 2011 Oct; 167(10):721-8. PubMed ID: 21906768
[TBL] [Abstract][Full Text] [Related]
15. [A single-center, retrospective analysis of relapse and progression patterns of primary central nervous system lymphoma: can whole brain radiotherapy be replaced?].
Qin Y; Liu R; Zhang X; Zhang W; Ren C; Wu D
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Apr; 43(4):499-506. PubMed ID: 37202184
[TBL] [Abstract][Full Text] [Related]
16. Early whole brain radiotherapy in primary CNS lymphoma: negative impact on quality of life in the randomized G-PCNSL-SG1 trial.
Herrlinger U; Schäfer N; Fimmers R; Griesinger F; Rauch M; Kirchen H; Roth P; Glas M; Bamberg M; Martus P; Thiel E; Korfel A; Weller M
J Cancer Res Clin Oncol; 2017 Sep; 143(9):1815-1821. PubMed ID: 28434043
[TBL] [Abstract][Full Text] [Related]
17. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.
Thiel E; Korfel A; Martus P; Kanz L; Griesinger F; Rauch M; Röth A; Hertenstein B; von Toll T; Hundsberger T; Mergenthaler HG; Leithäuser M; Birnbaum T; Fischer L; Jahnke K; Herrlinger U; Plasswilm L; Nägele T; Pietsch T; Bamberg M; Weller M
Lancet Oncol; 2010 Nov; 11(11):1036-47. PubMed ID: 20970380
[TBL] [Abstract][Full Text] [Related]
18. Long-term survival in AIDS-related primary central nervous system lymphoma.
Gupta NK; Nolan A; Omuro A; Reid EG; Wang CC; Mannis G; Jaglal M; Chavez JC; Rubinstein PG; Griffin A; Abrams DI; Hwang J; Kaplan LD; Luce JA; Volberding P; Treseler PA; Rubenstein JL
Neuro Oncol; 2017 Jan; 19(1):99-108. PubMed ID: 27576871
[TBL] [Abstract][Full Text] [Related]
19. Current management of primary central nervous system lymphoma.
Schultz CJ; Bovi J
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):666-78. PubMed ID: 20159361
[TBL] [Abstract][Full Text] [Related]
20. Current status and future of relapsed primary central nervous system lymphoma (PCNSL).
Tyson RM; Siegal T; Doolittle ND; Lacy C; Kraemer DF; Neutwelt EA
Leuk Lymphoma; 2003 Apr; 44(4):627-33. PubMed ID: 12769339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
